Constar maps 10-country contact lens import rules for 2026

Constar released a 2026 compliance guide showing how contact lens import rules differ across 10 major markets, from the US and EU to India, Saudi Arabia and South Korea. The map highlights local representative requirements, separate regulatory pathways and the certifications distributors need before shipping.

Why it matters: - Contact lenses are regulated as medical devices in most major markets, so importers face country-by-country approval, labeling and representative rules. - The guide is aimed at distributors and brand owners trying to avoid rejected shipments, delayed launches or seized containers. - Constar says broader certification coverage can help suppliers serve more markets from the same factory.

What happened: - Constar, a China-based contact lens OEM and ODM manufacturer, published a 2026 field guide covering compliance requirements in 10 markets. - The guide compares the regulator, route to market, local representative requirement and buyer checks before shipment. - Constar says it exports to more than 40 countries and is based in Baiyin, Gansu, China.

The details: - In the US, contact lenses fall under FDA Class II rules in 21 CFR Part 886 and generally require establishment registration, device listing and 510(k) clearance, with PMA for higher-risk products. - US foreign manufacturers must appoint a US Agent, and a valid prescription is required under the FDA Contact Lenses program and the FTC Contact Lens Rule. - In the European Union, lenses need CE marking under MDR 2017/745 and review by an independent notified body. - EU manufacturers outside the bloc must appoint an EU Authorized Representative, keep technical documentation for 10 years and meet UDI and post-market surveillance obligations. - In Great Britain, lenses require UKCA marking and MHRA registration, with a UK Responsible Person mandatory for non-UK manufacturers. - China classifies contact lenses as Class III devices and requires NMPA registration, in-country type testing, a local agent and proof of home-market approval. - Japan requires PMDA authorization under the PMD Act, a Japan-based Marketing Authorization Holder and J-QMS audits. - Australia requires ARTG inclusion and a local sponsor, while public advertising of contact lenses is restricted. - Canada requires a Medical Device License for Class III products, an Establishment License for importers and distributors, and ISO 13485-level quality controls. - Saudi Arabia requires SFDA product registration, Arabic-language labeling and documentation for customs clearance. - India now requires CDSCO import licensing through SUGAM, BIS certification under IS 15923, an Indian Authorized Agent, a Free Sale Certificate no older than 2 years and ISO 13485. - South Korea requires MFDS approval, a licensed local importer, Korean-language labeling and Korean-language documentation. - In Southeast Asia, rules remain fragmented: Indonesia uses AKL approval, Vietnam assigns lenses to Class B, Thailand requires product registration and a local representative, and Malaysia enforces its own Medical Device Authority standards. - Constar says its compliance portfolio includes FDA, CE 0197, TGA, SFDA, AKL and Vietnam Class B coverage. - The company says it operates six production facilities with combined capacity above 15 million lenses per month. - Constar says it holds US FDA 510(k), EU CE 0197, ISO 13485, TGA, SFDA, AKL and Vietnam Class B certifications.

Between the lines: - The guide underscores a key reality for contact lens brands: one approval does not travel across borders. - Local representation is a recurring requirement, which means market access depends on both product compliance and a country-specific importer structure. - The certification mix also signals how much regulatory depth matters as a sales advantage, not just a quality credential.

What's next: - Distributors are expected to re-check certification, prescription and labeling rules before each market entry. - Constar says buyers should verify market-specific certifications, batch-level documentation and customs history before placing orders. - The company also points to annual re-verification, especially as medical device rules continue to tighten in major markets.

The bottom line: - For contact lenses, compliance is the product strategy. The winners will be suppliers and distributors that can clear multiple regulators without rebuilding the supply chain for each country.